CONTRATOS DE INVESTIGACIÓN
Kontratua 29/2019
A phase 3 randomized, open-label (sponsor-blind), active-controlled, parallel-group, multi-center, event driven study in dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of daprodustat compared to recombinant human erythropoietin, following a switch from erythropoietin-stimulating agents.
Finantzatzailea:
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
date_range
Iraupena 2019(e)ko martxoa-(a)k 08-(e)tik 2020(e)ko otsaila-(a)k 29-(e)ra izan da
(12 months)
Nazioarteko (UE ez)-arlokoak. Zuzeneko emakida-aren araubidean eman da.
Ikertzaileak
Gabriel de
Arriba de la Fuente
Arduraduna